Contract HHSO100201600023C
Regeneron Pharmaceuticals Inc · Department Of Health And Human Services · March 19, 2026
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on March 19, 2026 for $8.60 million (current value) of work in research and development in biotechnology. Performance is in Tarrytown, NY. It was awarded under full and open competition. It uses cost-plus contract pricing. If all options are exercised, the contract could reach $10.76 million.
Contract details
- PIID
- HHSO100201600023C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Tarrytown, NY
- First action
- March 19, 2026
Description
REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT
Modification timeline
-
March 19, 2026Mod P00006 · Close Out$8.60M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
| Transnetyx, Inc | Department Of Health And Human Services | February 26, 2026 | $4.1K |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201600023C?
Contract HHSO100201600023C is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Health And Human Services on March 19, 2026 for $8.60 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSO100201600023C?
Regeneron Pharmaceuticals Inc won contract HHSO100201600023C from Department Of Health And Human Services.
How much is contract HHSO100201600023C worth?
Contract HHSO100201600023C has obligated $0 to date but carries a potential ceiling of $10.76 million if fully funded and all options are exercised.